ADMA Adma Biologics Inc

ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

$2.68  +0.18 (7.20%)
As of 10/04/2022 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/17/2013
Outstanding shares:  196,357,149
Average volume:  3,874,077
Market cap:   $477,147,872
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B9NSBM2
Valuation   (See tab for details)
PE ratio:   -6.27
PB ratio:   3.87
PS ratio:   8.60
Return on equity:   -61.67%
Net income %:   -141.07%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy